Mar 15, 2019 / Reports

March 2019 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 15, 2019 / Fact Sheets

Fact sheet on MedPAC’s March 2019 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 15, 2019 / Press Releases

MedPAC releases March 2019 Report to the Congress: Medicare Payment Policy

Research Areas:

Ambulatory Care Settings, Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Medicare Spending and Financing, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality

Mar 07, 2019 / Presentations

Medicare Advantage encounter data

Research Areas:

Private Plans

Mar 04, 2019 / Comment Letters

MedPAC comment on CMS’s advance notice of methodological changes for CY 2021 for Medicare Advantage–Part I, CMS-HCC risk adjustment model

Research Areas:

Private Plans

Mar 01, 2019 / Comment Letters

MedPAC comment on CMS’s advance notice of methodological changes for CY 2020 for Medicare Advantage (Parts 1 and 2)

Research Areas:

Private Plans

Mar 01, 2019 / Chapters

Chapter 13: The Medicare Advantage program: Status report (March 2019 report)

Research Areas:

Private Plans, Quality

Mar 01, 2019 / Chapters

Executive summary (March 2019 report)

Research Areas:

Beneficiaries and Coverage, Delivery System Reforms, Drugs, Devices, and Tests, Hospitals, Physicians And Other Health Professionals, Post-Acute Care, Private Plans, Quality, Regional Issues

Jan 16, 2019 / Comment Letters

MedPAC comment on CMS’s proposed rule on modernizing Part D and Medicare Advantage to lower drug prices and reduce OOP expenses

Research Areas:

Delivery System Reforms, Drugs, Devices, and Tests, Private Plans

Dec 18, 2018 / Comment Letters

MedPAC comment on CMS’s proposed rule on Medicare Advantage (Part C)

Research Areas:

Private Plans, Quality